Astract. The effects of chronic uremia and glucagon administration on glucagon-stimulable adenylyl cyclase in rat liver were assessed by determinations of adenylyl cyclase activities, specific iodoglucagon binding, and the activity of the stimulatory regulatory component of adenylyl cyclase. Glucagon-stimulated adenylyl cyclase was reduced in uremia to 75-80% of control levels (P < 0.05), in the presence or absence of saturating levels of guanosine triphosphate (GTP) and 5'-guanylylimidodiphosphate [GMP-P(NH)P]. Although these changes were accompanied by a concomitant 20% reduction in sodium fluoride-stimulated activity, basal, GTP-, GMP-P(NH)P-, and manganese-dependent adenylyl cyclase activities were unchanged. Using [125I-Tyr'0]monoiodoglucagon as a receptor probe, the number of high affinity glucagon-binding sites was reduced 28% (P < 0.01) in uremic as compared with control liver membranes. However, the affinity ofthese binding sites was unaltered. The S49 cyC-reconstituting activity with respect to both GMP-P(NH)P-and isoproterenol plus GTP-stimulable adenylyl cyclase was unaltered in membranes from uremic as compared with control rats. Intermittent glucagon (80-100 ,g) injections administered at 8-h intervals to normal rats reproduced all ofthe above described effects ofchronic experimental uremia on the adenylyl cyclase system. It is concluded that changes in the hormone-stimulable adAddress all reprint requests to Dr. Garber.
Introduction
Abnormal carbohydrate metabolism is a frequent concomitant of chronic renal disease (1) (2) (3) . As the result, in part, of the diminished renal clearance of glucagon, hyperglucagonemia is frequently observed in renal insufficiency (4, 5) . These increased immunoreactive glucagon levels result from increases in a number of molecular weight species, each of which may have glucagon-like immunoreactivity if not biological activity (6) (7) (8) . Glucagon-stimulable adenylyl cyclase activity in liver of uremic rats has been found to be increased (9, 10) . Other more indirect assessments have inferred a decreased activity of this enzyme in chronic uremia (1 1) . In light of these discordant data and to determine the impact of the uremic state on the hormone-stimulable adenylyl cyclase complex, we have used a monoiodinated glucagon as a probe of glucagon receptor density and affinity in membrane preparations of rat liver (12) , and have now developed and validated reconstitution assays using S49 cyc lymphoma cell membranes to measure the activity ofthe stimulatory regulatory component which links the glucagon receptor to the catalytic component of adenylyl cyclase. The effects of chronic uremia have been compared with the effects of intermittent glucagon administration in vivo on these parameters in rat liver. The implications ofthese findings for the regulation of hormonestimulable adenylyl cyclase activities are discussed.
Membrane preparations
The livers from uremic, normal, or glucagon-treated rats were quickly removed, placed on ice, and the membranes prepared according to the procedure ofNeville (15) as modified by Pohl et al. (16) . The membranes were then stored at -80°C. Cyc murine lymphoma S49 cells were grown and membranes (cyc membranes) prepared by Dr. Ravi Iyengar (Department of Cell Biology, Baylor College of Medicine) using procedures described elsewhere (17, 18) .
Adenylyl cyclase assays
Liver membranes (8) (9) (10) (11) (12) Mg protein) were incubated for 10 min at 30°C in a final volume of 50 Ml containing 0.1 mM [a-32P]ATP (1,000-1,500 cpm/pmol), 5 mM MgCI2, 1 mM EDTA, 1 mM[3H]cAMP (-10,000 cpm), 25 mM Tris-HCI, the indicated additives, and an ATP-regenerating system consisting of 0.02 mg/ml myokinase, 0.2 mg/ml creatine phosphokinase, and 20 mM creatine phosphate. The incubations were terminated by the addition of 100 Ml of a stop solution consisting of 40 mM ATP, 10 mM ofcAMP, and 1% sodium dodecyl sulfate.
[32P]cAMP formed was quantitated by the method of Salomon et al. (19) as modified by Bockaert et al. (20) . Both the ATP and the reagents used to regenerate it during the assays were purified from contaminating "GTP-like" materials as described elsewhere (21, 22 ).
1. Abbreviations used in this paper: GMP-P(NH)P, 5' 10 mM to chelate excess MgCI2 and the mixtures centrifuged in the cold at 100,000 g for 60 min. The supernatants were then warmed at 30°C for 5 min yielding the cholate extracts in which regulatory component activity was measured by reconstitution of GMP-P(NH)P or isoproterenol plus GTP-stimulated adenylyl cyclase activities in cycmembranes. As shown under Results, the above procedure results in a recovery of -75% of the total regulatory component activity measurable in the membrane-cholate mixtures.
Reconstitution of GMP-P(NH)P-stimulated activity in cyC membranes. Cholate extracts were diluted 25-fold or more with dilution medium consisting of 1.5 M KCI and 40 mM ,-mercaptoethanol. CyCreconstituting activity was then assayed by adding 10 Ml of the diluted, warmed cholate extracts to 10 Mul of cyc--membrane suspension (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) Mg in 1 mM dithiothreitol and 25 mM Na-HEPES, pH 8.0), keeping this mixture in the cold for 10-30 min, and assaying for GMP-P(NH)Pstimulated cyc adenylyl cyclase activity by further addition of 30 
Variability of results
The activity values obtained for a given membrane cholate extract were reproducible from day to day within 10% limits. Replicates within a given assay agreed within 5%. As prepared, cholate extracts could be stored at -800C without loss of activity for up to 4 mo, the longest time tested.
Although cholate extracts from different control liver membrane batches gave very similar cyc-reconstituting activities (as tested in a single assay), the absolute values ofcyc--reconstituted activities obtained (i.e., picomoles of cAMP formed under the assay conditions) varied by as much as fivefold depending on the batch of cyc-membranes used. This is owing to the fact that reconstituted activities depend on the quality of the cyc adenylyl cyclase system used to assay for regulatory component. In spite of these variations which relate to variability in the growth rate ofcells and the cell density at the time ofharvest, reconstituted activities were always proportional to micrograms of cholate extract protein added. Thus, the cyc-membranes used provided linear assays ofreconstituting activity. For these reasons, all studies in which regulatory component activities from various liver membrane preparations are compared were measured in single experiments using a single batch of cyC membranes. Protein was determined by the method of Lowry et al. (24) .
Results
Effects of uremia. The impact of chronic uremia on glucagonstimulable adenylyl cyclase in liver was assessed in membrane preparations of rats made chronically uremic by surgical techniques described previously (13, 14) . Although basal adenylyl cyclase was not different in uremic as compared with control membranes (9.9±0.9, 10.3±2.8 pmol cAMP formed/min per mg membrane protein, respectively; x±SD, n = 6), glucagonstimulable activity was decreased 27% in uremia (53.2±4.5, 39.1±6.1; P < 0.05) (Table I) . No significant effect on the concentration of glucagon required for half-maximal stimulation Membranes were incubated and adenylyl cyclase activity determined as described under Methods in the absence and presence of 10 'UM GTP, 10 AM GMP-P(NH)P, 10 mM NaF, 10 mM MnCI2, and 1 gM glucagon separately or in combination as indicated. If MnCl2 was added, MgCI2 was omitted. Membranes were incubated for 10 min at 32.50C as described more completely in Methods. Values shown are the mean±SD of at least six experiments. * P < 0.05 was noted in uremic as compared with control rats (Fig. 1) . The stimulations by saturating glucagon in the presence ofGTP and GMP-P(NH)P were reduced by 14 and 17%, respectively (P < 0.05) ( Table I) . Although the NaF-stimulated activity was reduced 19% (P < 0.05), GTP, GMP-P(NH)P, and MnC12 ac- tivities were not different in uremic as compared with control preparations.
The activity of the guanine nucleotide-binding a-subunit of regulatory component was next examined in control and uremic rats by using two methods of assessment. First, a reconstitution of GMP-P(NH)P-stimulable adenylyl cyclase activity in membranes of S49 cyc lymphoma cell membranes was performed by using regulatory component activity extracted from rat liver membranes with cholate. Second, the ability of added regulatory component extracted from liver membranes to confer, in the presence of GTP, isoproterenol stimulation to adenylyl cyclase in S49 cyc-cell membranes was assessed. The optimal conditions required for these reconstitution assays were investigated and validated. These studies indicated that reconstitution of GMP-P(NH)P-stimulated cyc-adenylyl cyclase activity was best observed in the presence of 20 mM ,B-mercaptoethanol and 0.75 M KCl, which both reduced the lag in appearance in reconstituted activity and led to a constant accumulation of cAMP for 60-80 min. Assays were performed routinely for 40 min. Optimal extraction of reconstituting activity from hepatic membranes was obtained in the presence of 1% cholate, I mM EDTA, and 10 mM MgCl followed by chelation of excess MgCl by postaddition of 11 mM EDTA. Coextracted cyclizing activity was inactivated by heating without major loss (10%) of the reconstituting activity. Optimal reconstitution of isoproterenol plus GTP-stimulated activities required cholate concentrations to be <0.1% during the first reconstitution phase of assay. The reconstituted adenylyl cyclase activity was augmented by KCI addition in the presence of low but not high cholate concentrations. The dependency on time of the reconstitution of isoproterenol-stimulable adenylyl cyclase activity and S49 cyc-cell membranes was such that hormonal reconstitution incubations were carried out for 10 min rather than 40 min. Under these conditions, the reconstitution of the hormonally sensitive adenylyl cyclase activity was linearly dependent on the quantity of regulatory component (cholate extract added) provided the quantity ofliver membrane-derived protein in the cholate extract added to the reconstitution assays was <1 Mg.
We investigated the efficiency with which regulatory component was extracted from liver membranes using the procedures described above. Nielsen et al. (25) have shown that, in cyc cell membranes, reconstitution ofGMP-P(NH)P-stimulated activation of adenylyl cyclase occurs not only with fully solubilized regulatory component, but also with partially solubilized component such as would be present in an adsorbed form on membranes treated with 1% cholate. We, therefore, measured "total reconstituting activity" by mixing the membrane-cholate mixtures with cyc-membranes and assessing the resulting GMP-P(NH)P-stimulated activity, which reflects totally reconstituted cyc activity, undisturbed liver membrane activity, and some as yet undefined effect of liver membrane-bound regulatory component on cyC membrane-bound adenylyl cyclase. We found that before warming, cholate extracts contained -75% of the "maximally" measurable regulatory component activity (not shown). Based on these preliminary studies, it is apparent that (a) the bulk of the regulatory component activity can be extracted from liver membranes, (b) the extracts obtained can be warmed to inactivate endogenous catalytic activity without substantial loss of regulatory component activity, and (c) reconstituted activities can be used to quantitate regulatory component activity, provided that the cholate is diluted sufficiently and that both KCI and f-mercaptoethanol are added to accelerate the reconstitution process.
Using these techniques, regulatory component activity was determined in liver membrane preparations of uremic and control rats. Both the "extractability" and cyc-reconstituting activity of regulatory component activity, as assessed by reconstitution of GMP-P(NH)P-stimulable adenylyl cyclase activity, were not different in membranes of uremic as compared with control rats (Table II) . Similarly, the capacity of regulatory component from membranes ofuremic rats to reconstitute cyc isoproterenol plus GTP-stimulated activity was also unchanged when compared with controls. Thus, using these two assessments of regulatory component activity, the activity of this coupling protein in uremic membranes was found to be unaltered as compared with membranes from control animals.
Because the foregoing data suggest potential alterations of glucagon receptor function in liver membranes of uremic rats, the number of glucagon receptors and their affinity were examined using monoiodinated glucagon. Binding studies with this highly purified ['25I]iodoglucagon were performed in hepatic membrane preparations from control and uremic rats, and the data were analyzed by the method of Scatchard (23) . The data obtained (Fig. 2) indicate the existence in liver membranes of an apparently single population of high affinity binding sites for the probe. No differences in receptor affinity for this radiolabeled ligand could be detected in membranes of uremic as compared with control animals (Table III) Effect ofglucagon administration. It has been suggested that the hyperglucagonemia of chronic renal failure may alter glucagon-responsive adenylyl cyclase activity (9-1 1). For this reason, potential effects of intermittent glucagon injections on glucagonsensitive adenylyl cyclase in rat liver were investigated. Liver membranes were prepared from rats administered 80-100 yg glucagon (subcutaneous) at 8-h intervals for 3 d; the properties of their adenylyl cyclase system were compared with those in control liver membranes prepared in parallel. As shown in Tables  IV-VI and Figs. 3 tivities ofadenylyl cyclase were reduced, but basal, GTP-, GMP-P(NH)P-, and manganese-dependent activities were unchanged; the a-subunit activity of the stimulatory regulatory component was unaltered; and glucagon receptor levels but not affinity were reduced. Glucagon-treatedt 10.5±0.4 (n = 6) 0.66±0.05 (n = 6)
Liver membranes from control and glucagon-treated rats (5-7 mg protein/ml) were extracted as described under Methods yielding cholate extracts of 2.6-2.9 mg protein/ml. Each of the extracts was then assayed in triplicate (controls) or duplicate (glucagon-treated) at three different dilutions for reconstitution of GMP-P(NH)P-stimulated and isoproterenol plus GTP-stimulated cyc-adenylyl cyclase activities. Specific activities for reconstitution of cyc adenylyl cyclase were calculated, confirmed to be independent of sample dilution, and averaged to give the values reported in the 10-8
10-7
Glucagon (M) Figure 3 . Effect of treatment of rats with glucagon on responsiveness of liver membrane adenylyl cyclase to glucagon. Rats were treated with glucagon (100 ,ug/rat, subcutaneous) twice daily for 3 d and killed 12 h after the last injection. Liver membranes were prepared from control (-* -) and glucagon-treated (---A& ---) rats and incubated with varying concentrations of glucagon for determination of adenylyl cyclase activities as described under Methods.
Discussion
Altered glucagon stimulation ofliver adenylyl cyclase in uremia. Disparate conclusions regarding hepatic glucagon-sensitive adenylyl cyclase activity in chronic uremia have been reached (9- [1251 ] lodoglucagon bound (pmoles/mg protein) (29) (30) (31) . Similarly, we have reported elevated levels of catecholamines and a loss of responsiveness of the epinephrine-stimulable adenylyl cyclase in skeletal muscle of chronically uremic rats (32) . It is therefore possible that primary alterations in either the epinephrine-or the parathyroid hormone-stimulable adenylyl cyclases or in both may account for the decreased glucagon responsiveness in uremia (33, 34) . However, this possibility also appears to be somewhat unlikely since, as we show here, primary alterations both of regulatory component activity and in glucagon-receptor affinity are not observed. Finally, chronic uremia is associated with hyperglucagonemia (4) (5) (6) (7) (8) , and changes in glucagon-stimulated cyclase activity might be the result primarily of the elevated circulating glucagon levels. We, therefore, tested whether or not glucagon administration to rats might mimic in any way the changes in adenylyl cyclase regulation observed in uremia. Glucagon-specific membrane receptors were decreased to a similar extent as in uremia; glucagonand sodium fluoride-stimulated but not basal, GTP-, GMP-P(NH)P-, or manganese-dependent adenylyl cyclase activities were reduced to an extent similar to that observed in chronic uremia. There were no changes observed in a-subunit function of the regulatory component as suggested by reconstitution assays. Taken as a whole, these findings in glucagon-treated animals are entirely consistent with a glucagon-induced desensitization of the glucagon-stimulable adenylyl cyclase in rat liver, the decreased adenylyl cyclase activity in response to glucagon being the result primarily of the decreased glucagon-receptor density following glucagon administration (35) (36) (37) . Since the data obtained from the glucagon-injected animals are in every way similar to the data obtained on the same hormone-stimulable adenylyl cyclase in liver of uremic rats, it would seem reasonable to conclude that the changes in liver of chronically uremic animals may derive primarily from a glucagon-induced desensitization ofthe hormone-sensitive adenylyl cyclase complex rather than from a nonspecific toxic effect of the uremic state.
Altered fluoride stimulation of adenylyl cyclase in uremia and glucagon treatment. Decreased sodium fluoride-stimulated adenylyl cyclase activity without concomitant changes in either basal, manganese-dependent, and GTP-or GMP-P(NH)P-stimulated activity was noted in hepatic membranes from both uremic and glucagon-treated as compared with control animals. Such a dissociation between nucleotide-stimulated as compared with fluoride-stimulated activities has not been reported previously. Both sodium fluoride and guanine nucleotides appear to exert their effects by interacting, as do hormone receptors, with the regulatory component (38) (39) (40) (41) (42) . Detailed studies by Gilman and collaborators (43) (44) (45) (46) have shown that the stimulatory regulatory component is formed of at least two distinct subunits: first, an a-subunit which is the substrate for ADP ribosylation (47) and which regulates the catalytic activity of adenylyl cyclase per se, and second, a ,B-subunit for which no specific function has yet been assigned with certainty. The cyc S49 cell membranes used lack only the a-subunit of the regulatory component (48, 49) , but do contain the (3-subunit. Since activation of regulatory component is dependent on or at least associated with its dissociation into the individual subunits (50, 51) , the reconstitution assay used actually assesses the activated a-subunit fraction but not the (3-subunit. Guanine nucleotides exert their action on adenylyl cyclase by interacting with and binding to the a-subunit of the regulatory component (50, 51) . However, while sodium fluoride exerts its action on adenylyl cyclase at the level ofthe regulatory component (46) , the specific subunit at which it interacts is not known, nor is the precise mechanism by which fluoride activates the regulatory component.
The results of the present study show clearly that both guanine nucleotide regulation of adenylyl cyclase, as assessed in the absence of hormone, and the cyc-reconstituting activity are unaltered in uremic and glucagon-treated as compared with control liver membranes. These findings strongly indicate that the a-subunit of the regulatory component is unaltered. Since sodium fluoride but not nucleotide regulatory activity was decreased in uremic as compared with control liver membranes, it is possible that this reflects an alteration either of the level of another subunit or ofthe capacity ofanother subunit to interact with the a-subunit of the stimulatory regulatory component. This other subunit may be the ,8-subunit, or it may well be an as yet undefined factor regulating sodium fluoride but not guanine nucleotide stimulation of cyclic AMP formation. It is of interest that treatment of MDCK cells with glucagon results in a loss ofglucagon-and sodium fluoride-stimulated but not basal or guanine nucleotide-regulated adenylyl cyclase activities or in cyc-reconstituting activity (52) . These findings are essentially identical to the pattern ofalterations in adenylyl cyclase activities reported here. Thus, the dissociation between guanine nucleotide and sodium fluoride-stimulated activity observed in this study may not be a phenomenon restricted solely to uremia or to rat liver and may therefore reflect a more common phenomenon of adenylyl cyclase regulation.
